Patent · US Active

Kinase inhibitor

US8658649B2 · kind B2 · utility

0Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2009
Grant dateFeb 25, 2014
Priority date
Expiry dateSep 7, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to a compound of formula (I):and the prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs. Such a compound has valuable pharmaceutical properties, in particular the ability to inhibit protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.